Case reports of etanercept in inflammatory dermatoses.

 Am Acad Dermatol. 2006 Mar;54(3 Suppl 2):S139-42. Norman R, Greenberg RG, Jackson JM. Abstract Skin disfigurations and pruritus can pose severe threats to quality of life, and treatment options for patients with recalcitrant diseases are limited. Tumor necrosis factor alpha, a proinflammatory cytokine, … Read More

Botulinum toxin in dermatology – beyond wrinkles and sweat.

J Cosmet Dermatol. 2005 Dec;4(4):223-7. Wollina U, Konrad H, Petersen S. Source Department of Dermatology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany. wollina-uw@khdf.de Abstract Botulinum toxin (BTX) types A and B have been used with success in cosmetic dermatology and hyperhidrosis treatment. The present … Read More

Severe impairment of quality of life in Hailey-Hailey disease.

Acta Derm Venereol. 2005;85(2):132-5. Gisondi P, Sampogna F, Annessi G, Girolomoni G, Abeni D. Source Istituto Dermopatico dell’Immacolata, IRCCS, 00167 Rome, Italy. Abstract Hailey-Hailey disease (a skin fragility disorder) runs a chronic course and may cause important disability. However, little has been formally investigated concerning … Read More

Benign familial pemphigus: little benefit from superficial radiotherapy.

Australas J Dermatol. 2002 Nov;43(4):305-8. Roos DE, Reid CM. Source Department of Radiation Oncology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. droos@mail.rah.sa.gov.au Abstract Benign familial pemphigus (Hailey-Hailey disease) is a rare relapsing-remitting epidermal blistering disease palliated by a multitude of medical and … Read More